Clinical Trials Logo

Clinical Trial Summary

The main objectives of this single-arm pilot trial are to investigate the feasibility of our protocol in terms of 1) recruitment, 2) adherence, 3) tolerability, 4) acceptability and 5) retention. We aim to recruit 20 participants with advanced colon cancer (stage 3-4) who will have assessments of their autonomic nervous system function, carcinoembryonic antigen (CEA) levels, and patient-reported outcomes. Thereafter, patients will be directed to a nearby field clinic to receive twice-weekly cervical assessments & high-velocity, low-amplitude (HVLA) cervical adjustments for a period of 6 weeks. Re-assessments will be performed following 2 weeks and 6 weeks of chiropractic care.


Clinical Trial Description

After providing informed consent, individuals will undergo 6 weeks of chiropractic care. Throughout these 6 weeks there will be three assessments (Day 1, Week 2, and Week 6) that each include the following: 1. Isometric hand grip 2. Postural challenge 3. Patient-reported outcome surveys 4. Off-site blood draw for CEA level testing (only Day 0 and Week 6) Each assessment will consist of the following recordings: 1. Electrodermal activity [EDA] 2. Impedance cardiography [ICG] 3. Electrocardiogram [ECG] ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05310565
Study type Interventional
Source Life University
Contact
Status Withdrawn
Phase N/A
Start date January 1, 2025
Completion date March 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04907643 - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes N/A
Completed NCT00309530 - Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C Phase 3
Completed NCT04342676 - Lymph Node Ratio and Kras Mutation in R Colon Cancer Phase 3
Enrolling by invitation NCT05179889 - Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer Phase 2/Phase 3
Withdrawn NCT05433402 - Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer Phase 1/Phase 2
Recruiting NCT06108310 - ArTificial inTelligence-based RAdiogenomics in Colon Tumors
Not yet recruiting NCT04488159 - Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer Phase 3
Recruiting NCT05194878 - Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers Phase 3